Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-
related death. The remarkable improvements in treating HCC achieved in the last years …

Patients with hepatocellular carcinoma should be managed with a multidisciplinary
approach framed in a network where all the diagnostic techniques and therapeutic …

Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second
leading cause of cancer-related mortality worldwide. In this review, we made a review on …

Simple Summary Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with
global impact, especially in the context of the rising epidemic of metabolic-dysfunction …

Treatment allocation is extremely complex in patients with hepatocellular carcinoma (HCC)
because this neoplasm arises, in most cases, in patients with cirrhosis and additional …

Introduction This document is a summary of the French Intergroup guidelines regarding the
management of hepatocellular carcinoma (HCC) published in March 2019. Method It is a …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second
leading cause of cancer-related mortality worldwide. This review is an updated version that …

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies
worldwide. Due to late diagnosis and advanced underlying liver cirrhosis, only limited …

Many guidelines for hepatocellular carcinoma (HCC) have been published and updated
globally. In contrast to other cancers, there is a range of treatment options for HCC involving …